Acquisition - April 24, 2015
MD Biomedical Joins Senzime
Umeå spin-off and medtech company MD Biomedical has been acquired by Swedish company Senzime as a subsidiary, according to Biotech Umeå. MD Biomedical has developed a probe called Onzurf, which can be used to monitor the status of an organ from the surface. The development was based on MD Biomedical’s research at Umeå University and […]
Uncategorized - April 22, 2015
‘Scaffolding’ a Fix for Torn Tissue
Researchers at iNANO at Aarhus University are testing a type of “scaffolding” made from biodegradable nanofibers that takes over for structures in the body that hold cells together and support body tissue. “So far we’ve tested it on mice and rats. But there’s still some way to go before we can use this scaffolding on […]
Acquisition - April 22, 2015
Attorney Joins Virtual Management Team
Attorney Stefan Wendén, a managing partner in a Swedish law firm, is now part of the Malmö-based research park Medeons first virtual management team. The new concept is being tested at Richter Life Science Development, founded by Agneta Richter Dahlfors, professor of microbiology at Karolinska Institutet, according to Swedish Life Science. In a virtual management […]
Drug Development Pharma - April 22, 2015
More Good News for Kidney Transplant Drug
Trials of once-daily Envarsus® XR, an investigational drug under FDA review for the prevention of organ rejection in adult kidney transplant patients, demonstrated that a lower dose in African-American patients is sufficient for therapeutic tacrolimus blood concentrations, compared to twice-daily immediate release tacrolimus, according to Veloxis. Veloxis is seeking an order requiring the FDA to […]
Uncategorized - April 21, 2015
Finland Ready for mHealth
Finland offers the third best market prerequisites for the mHealth business among the EU countries, according to a survey conducted by research2guidance in collaboration with HIMSS Europe. More than 4,000 app developers, healthcare professionals and mHealth practitioners contributed to the “The EU Countries’ mHealth App Market Ranking” survey. mHealth stands for mobile Health, which refers […]
Acquisition - April 21, 2015
Novo Nordisk, Janssen Sign Pact
Novo Nordisk A/S and Janssen Biotech, Inc. have signed an agreement that will allow Janssen to acquire an exclusive global license to further develop and commercialize a clinical program focused on therapy within autoimmune diseases. The program targets modulation of certain immune cells via a cell surface receptor (NKG2D receptor), according to Novo Nordisk. The […]
